Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 87
Selected: 0
NCT IDTitle
NCT05339646A Phase I Clinical Study of SSD8432 in Healthy Adult Subjects
NCT06686745Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
NCT05369676To Evaluate SSD8432/ Ritonavir in Adults With COVID-19
NCT06698965Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
NCT05803135Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis
NCT02088515Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
NCT02650375Study of Metatinib Tromethamine Tablet
NCT02269904Fluorouracil Implants Used for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastric Cancer.
NCT07050459A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06331559Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
NCT01909856The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy
NCT01368419Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
NCT01893151Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI
NCT07007988A Phase I Study of SIM0388 in Participants With Malignant Ascites.
NCT02283476The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.
NCT07345364A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants
NCT06536036Evaluate the Effects of Food on the Pharmacokinetics of SIM0270
NCT02453464A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer
NCT06370416the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
NCT04671849An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations.
NCT07618260SIM0613 in Participants With Advanced Solid Tumors
NCT07361003A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
NCT07357610An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
NCT03424928A Pilot Bioequivalence Study of Pomalidomide
NCT05731804Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir
NCT05373433To Evaluate SSD8432/Ritonavir in Adults With COVID-19
NCT05826249Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects
NCT05718219Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors
NCT05200728The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers
NCT03763123A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.
NCT06326723Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects
NCT06680921A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
NCT01772732Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC
NCT06022354To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
NCT01327235Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
NCT01459081Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
NCT02275299Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
NCT01554917A Study of Iguratimod in Patients With Active Rheumatoid Arthritis
NCT05569057A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
NCT01548001Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis
NCT05781360A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors
NCT05665647Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants
NCT01469910Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Subjects
NCT05506176A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19
NCT05781386A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
NCT04440436Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients
NCT06375044Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
NCT03588494Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer
NCT05148195A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
NCT06010693A Study of Daridorexant in Chinese Patients With Insomnia Disorder